Gene · 6921
NIH grants1,232
NIH grants whose papers are about the gene, through NIH's grant-paper links.
461 to 480 of 1,232
Download this page as JSON| Grant | Title | ELOC papers | Newest fiscal year |
|---|---|---|---|
| R01GM122749 | Discovery of Selective Inhibitors for Histone Methyltransferases | 4 | 2020 |
| T32GM008326 | MOLECULAR BIOPHYSICS TRAINING PROGRAM | 4 | 2020 |
| K01AG052627 | Mechanisms Controlling BubR1 Regulation of Cancer and Aging | 3 | 2020 |
| R01AI030927 | HIV Host-Cell Interactions | 3 | 2020 |
| R01GM124559 | Towards a comprehensive multiscale 3D human interactome network | 3 | 2020 |
| T32GM007270 | Training in Cellular and Molecular Biology | 3 | 2020 |
| T32GM007618 | Medical Scientist Training Program | 3 | 2020 |
| U24CA210949 | Batch effects in molecular profiling data on cancers: detection, quantitation, interpretation, and correction | 3 | 2020 |
| U24CA210950 | Integrated analysis of protein expression data from the Reverse Phase Protein Array (RPPA) platform | 3 | 2020 |
| U24CA210990 | UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis Network | 3 | 2020 |
| P50CA058236 | SPORE in Prostate Cancer | 2 | 2020 |
| R01AI122747 | Decoding the Chlamydia inclusion membrane protein-host protein interactome | 2 | 2020 |
| R01CA200573 | Characterizing the signaling pathways that regulate Skp2 oncogenic function | 2 | 2020 |
| R01CA200651 | Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization | 2 | 2020 |
| R01GM124256 | Crosstalk between post-translational regulations of the FNIP co-chaperones and their impact on Hsp90 chaperone function and drug binding | 2 | 2020 |
| R50CA211252 | Investigating targeted degradation of c-Met to realize more effective cancer treatment | 2 | 2020 |
| T32GM007185 | Research Tranining in Cellular and Molecular Biology | 2 | 2020 |
| U24CA210957 | OHSU Center for Specialized Data Analysis as part of the GDAN | 2 | 2020 |
| DP2GM140924 | Decoding the regulation and functions of mammalian 12h-clock | 1 | 2020 |
| F30AI143401 | Harnessing the RNA-Cleaving Properties of CRISPR-Cas13a for Applications to HIV Detection and Latency | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/grants?page=24